Pharmacologic control of fetal lung development.
D002395:Catecholamines / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000033:anatomy & histology / Q000187:drug effects* / Q000196:embryology* / Q000502:physiology; D010713:Phosphatidylcholines / Q000032:analysis; D010743:Phospholipids / Q000032:analysis; D011247:Pregnancy; D011663:Pulmonary Surfactants; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000453:epidemiology; D013109:Sphingomyelins / Q000032:analysis
D002395:Catecholamines; D005938:Glucocorticoids; D010713:Phosphatidylcholines; D010743:Phospholipids; D011663:Pulmonary Surfactants; D013109:Sphingomyelins